![Max M. Søgaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max M. Søgaard
Teknisk/Vetenskaplig/F&U Direktör på
EXPRES2ION BIOTECH HOLDING AB
Profil
Max M.
Søgaard currently works at Expres2ion Biotech Holding AB, as Chief Scientific Officer from 2025.
Dr. Søgaard received his graduate degree from the University of Aarhus and doctorate degree from University College London.
Aktiva positioner av Max M. Søgaard
| Företag | Position | Start |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Teknisk/Vetenskaplig/F&U Direktör | 2020-01-01 |
Max M. Søgaards utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
16
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
